Alexandre Zanghellini is a co-founder of Arzeda and serves as its Chief Executive Officer. Along with Arzeda’s management team, he is responsible for day-to-day operations and also leads Arzeda’s product and technology development and IP strategy. Alex is one of the inventors of Arzeda’s synthetic biology platform for novel enzyme and metabolic pathway design and is a keen believer in the power of biotechnology to solve some of our biggest societal challenges. Before founding Arzeda, Alex held positions in research and development both in academia and industry. He holds a Ph.D. from the University of Washington and a M.Sc. Eng. from ENSTA/ParisTech in Paris, France.